Recent studies have shown that the PI3K/Akt signaling pathway is aberrantly activated in many cancer types, including CRC and that the activation of PI3K signaling promotes cancer formation through a variety of mechanisms, including the induction of cell proliferation, migration and cancer cell survival [30]–[32]. This evidence concerns the gene AKT1 and cancer.